Shield Therapeutics PLC (STX)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

6.00p

Buy

6.30p

arrow-down-0.05p (-0.81%)

Prices updated at 24 Jul 2026, 14:56 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Shield Therapeutics PLC is a commercial-stage specialty pharmaceutical company that delivers ACCRUFeR/FeRACCRU (ferric maltol), a differentiated pharmaceutical product, to address the unmet need for patients suffering from iron deficiency, with or wit ...
6.40p - 6.00p
12.50p - 4.30p
-
65.78m
-
150,000
1,283,574
-
2,681,125.62
2.54
1,067.84m
GB00BYV81293
-0.02
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.